Matthew J. Kolek

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

John F. Carlquist, Benjamin D. Horne, Joseph B. Muhlestein et al. · Journal of Thrombosis and Thrombolysis · 2006 · 215 citations

Thrombosis, Medicine, Hematology +6

Toll–like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes

Matthew J. Kolek, John F. Carlquist, Joseph B. Muhlestein et al. · American Heart Journal · 2004 · 136 citations

Inflammation, Toll-like Receptors, Metabolic Syndrome +15

Genetic Risk Prediction of Atrial Fibrillation

Steven A. Lubitz, Xiaoyan Yin, Henry J. Lin et al. · Circulation · 2016 · 107 citations · Full text

Use of an Antibacterial Envelope is Associated with Reduced Cardiac Implantable Electronic Device Infections in High‐Risk Patients

Matthew J. Kolek, William Dresen, Quinn S. Wells et al. · Pacing and Clinical Electrophysiology · 2012 · 88 citations · Full text

Efficacy of a Bio‐Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High‐Risk Subjects

Matthew J. Kolek, Neel Patel, Walter K. Clair et al. · Journal of Cardiovascular Electrophysiology · 2015 · 75 citations · Full text